Efficacy of Aerosol Combination Therapy of 13 Cis Retinoic Acid and Captopril for Treating Covid-19 Patients Via Indirect Inhibition of Transmembrane Protease, Serine 2 (TMPRSS2)

Condition:   Covid19 Interventions:   Combination Product: Aerosolized 13 cis retinoic acid plus Inhalation administration by nebulization captopril 25mg;   Drug: Drug: Standard treatment Standard treatment Sponsor:   Kafrelsheikh University Not yet recruiting

Source: ClinicalTrials.gov - October 8, 2020 Category: Research Source Type: clinical trials